Genus plc 8.1% potential upside indicated by Liberum Capital

Genus plc with ticker (LON:GNS) now has a potential upside of 8.1% according to Liberum Capital.



Liberum Capital set a target price of 6,000 GBX for the company, which when compared to the Genus plc share price of 5,515 GBX at opening today (08/11/2021) indicates a potential upside of 8.1%. Trading has ranged between 3,896 (52 week low) and 6,310 (52 week high) with an average of 159,303 shares exchanging hands daily. The market capitalisation at the time of writing is £3,633,645,535.

Genus PLC is a United Kingdom-based animal genetics company. The Company provides farmers with genetics that enable them to produce animal protein for breeding pigs and cattle, in the form of meat and milk. The Company’s operating segments includes Genus PIC, Genus ABS and Research and Development. The Genus PIC segment is engaged in porcine sales business. The Genus ABS segment is engaged in bovine sales business. The Company’s development activities include developing and maintaining its porcine genetic nucleus herd and bovine pre-stud herds. The Company operates approximately around 25 countries on six continents, with research laboratories located in Madison, Wisconsin, United States.